TELA Bio (TELA) Competitors $1.46 -0.02 (-1.35%) Closing price 04:00 PM EasternExtended Trading$1.47 +0.01 (+0.68%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. INGN, NNOX, INFU, CV, ELMD, BSGM, CVRX, KRMD, SGHT, and STIMShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Inogen (INGN), Nano-X Imaging (NNOX), InfuSystem (INFU), CapsoVision (CV), Electromed (ELMD), Biosig Technologies (BSGM), CVRx (CVRX), KORU Medical Systems (KRMD), Sight Sciences (SGHT), and Neuronetics (STIM). These companies are all part of the "medical equipment" industry. TELA Bio vs. Its Competitors Inogen Nano-X Imaging InfuSystem CapsoVision Electromed Biosig Technologies CVRx KORU Medical Systems Sight Sciences Neuronetics Inogen (NASDAQ:INGN) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability. Which has stronger earnings & valuation, INGN or TELA? Inogen has higher revenue and earnings than TELA Bio. Inogen is trading at a lower price-to-earnings ratio than TELA Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInogen$335.70M0.66-$35.89M-$1.06-7.70TELA Bio$75.32M0.77-$37.84M-$1.12-1.30 Does the media favor INGN or TELA? In the previous week, TELA Bio had 4 more articles in the media than Inogen. MarketBeat recorded 6 mentions for TELA Bio and 2 mentions for Inogen. Inogen's average media sentiment score of 0.95 beat TELA Bio's score of 0.30 indicating that Inogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive TELA Bio 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Is INGN or TELA more profitable? Inogen has a net margin of -7.58% compared to TELA Bio's net margin of -54.12%. Inogen's return on equity of -13.77% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Inogen-7.58% -13.77% -8.52% TELA Bio -54.12%-329.48%-57.34% Do analysts prefer INGN or TELA? Inogen currently has a consensus target price of $11.00, suggesting a potential upside of 34.80%. TELA Bio has a consensus target price of $4.50, suggesting a potential upside of 208.22%. Given TELA Bio's higher probable upside, analysts plainly believe TELA Bio is more favorable than Inogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00TELA Bio 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Do institutionals and insiders hold more shares of INGN or TELA? 89.9% of Inogen shares are held by institutional investors. Comparatively, 94.3% of TELA Bio shares are held by institutional investors. 1.5% of Inogen shares are held by insiders. Comparatively, 4.7% of TELA Bio shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, INGN or TELA? Inogen has a beta of 1.8, indicating that its share price is 80% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. SummaryInogen beats TELA Bio on 8 of the 14 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$57.84M$3.32B$6.01B$10.23BDividend YieldN/A2.29%5.66%4.69%P/E Ratio-1.3022.1185.3526.57Price / Sales0.77416.63582.95179.01Price / CashN/A47.1938.3262.20Price / Book2.0310.2112.726.53Net Income-$37.84M-$52.40M$3.30B$275.87M7 Day Performance-6.41%0.90%1.07%-1.40%1 Month Performance-7.01%12.36%7.61%5.16%1 Year Performance-38.66%30.17%79.71%31.51% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.3294 of 5 stars$1.46-1.4%$4.50+208.2%-39.1%$57.84M$75.32M-1.30120News CoverageAnalyst ForecastINGNInogen4.0263 of 5 stars$8.11-1.3%$11.00+35.6%-5.6%$222.27M$343.47M-7.651,030NNOXNano-X Imaging2.6176 of 5 stars$3.75+0.8%$8.50+126.7%-30.3%$214.94M$11.28M-4.17190News CoveragePositive NewsAnalyst ForecastINFUInfuSystem4.5355 of 5 stars$10.50+1.5%$13.50+28.6%+41.7%$214.47M$139.89M175.03410Positive NewsCVCapsoVisionN/A$4.53-1.1%$5.50+21.4%N/A$214.23MN/A0.0090News CoverageAnalyst ForecastELMDElectromed3.6968 of 5 stars$24.54+1.4%$36.25+47.7%+15.4%$201.97M$64M32.72160BSGMBiosig Technologies1.6707 of 5 stars$6.35+42.6%$10.00+57.6%+2,250.0%$199.35M$13K0.0050Gap DownHigh Trading VolumeCVRXCVRx2.6785 of 5 stars$7.78+3.0%$14.00+79.9%+20.1%$197.45M$51.29M-3.70160News CoverageAnalyst ForecastKRMDKORU Medical Systems2.0902 of 5 stars$3.84-3.0%$4.63+20.4%+66.1%$183.09M$33.65M-42.6780News CoveragePositive NewsAnalyst ForecastSGHTSight Sciences3.2557 of 5 stars$3.48flat$4.42+26.9%-40.4%$182.24M$79.87M-3.62210Positive NewsAnalyst ForecastSTIMNeuronetics1.8015 of 5 stars$2.66-1.8%$7.00+163.2%+219.6%$179.20M$74.89M-2.35180News CoverageAnalyst Forecast Related Companies and Tools Related Companies Inogen Competitors Nano-X Imaging Competitors InfuSystem Competitors CapsoVision Competitors Electromed Competitors Biosig Technologies Competitors CVRx Competitors KORU Medical Systems Competitors Sight Sciences Competitors Neuronetics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 10/10/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenIf you're a futures trader (or want to be one), this could be the biggest shift you'll ever see in the prop fi...Neuro Street Trading Academy | SponsoredThe best AI stock you aren’t watching (but Elon is)Elon Musk's AI empire is already being built... not in the spotlight, but in the background. One public cou...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredU.S. Government Sparking Crypto RallyAltcoin ETFs could surge prices (do this now) My "Crypto Bull Run Millionaire Blueprint" breaks down exactl...Crypto 101 Media | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
